Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP762785.RAkM1ks0KvgFBU3XPe32JRaIP82-giEelo2IF08Hod_zA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP762785.RAkM1ks0KvgFBU3XPe32JRaIP82-giEelo2IF08Hod_zA130_assertion type Assertion NP762785.RAkM1ks0KvgFBU3XPe32JRaIP82-giEelo2IF08Hod_zA130_head.
- NP762785.RAkM1ks0KvgFBU3XPe32JRaIP82-giEelo2IF08Hod_zA130_assertion description "[No significant difference was found in levodopa main outcome variables and dyskinesia incidence between the two groups of patients stratified by DAT VNTR polymorphism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP762785.RAkM1ks0KvgFBU3XPe32JRaIP82-giEelo2IF08Hod_zA130_provenance.
- NP762785.RAkM1ks0KvgFBU3XPe32JRaIP82-giEelo2IF08Hod_zA130_assertion evidence source_evidence_literature NP762785.RAkM1ks0KvgFBU3XPe32JRaIP82-giEelo2IF08Hod_zA130_provenance.
- NP762785.RAkM1ks0KvgFBU3XPe32JRaIP82-giEelo2IF08Hod_zA130_assertion SIO_000772 15190232 NP762785.RAkM1ks0KvgFBU3XPe32JRaIP82-giEelo2IF08Hod_zA130_provenance.
- NP762785.RAkM1ks0KvgFBU3XPe32JRaIP82-giEelo2IF08Hod_zA130_assertion wasDerivedFrom befree-20140225 NP762785.RAkM1ks0KvgFBU3XPe32JRaIP82-giEelo2IF08Hod_zA130_provenance.
- NP762785.RAkM1ks0KvgFBU3XPe32JRaIP82-giEelo2IF08Hod_zA130_assertion wasGeneratedBy ECO_0000203 NP762785.RAkM1ks0KvgFBU3XPe32JRaIP82-giEelo2IF08Hod_zA130_provenance.